TY - JOUR
T1 - Burden of impaired sleep quality on work productivity in functional dyspepsia
AU - Matsuzaki, Juntaro
AU - Suzuki, Hidekazu
AU - Togawa, Koji
AU - Yamane, Tsuyoshi
AU - Mori, Hideki
AU - Komori, Takahiro
AU - Masaoka, Tatsuhiro
AU - Kanai, Takanori
N1 - Funding Information:
This work was supported by a Grant-in-Aid for Scientific Research B (16H05291, to H.S.), from the Japan Society for the Promotion of Science (JSPS), MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1411003, to H.S.), the Princess Takamatsu Cancer Research grants (to H.S.), Keio Gijuku Academic Development Funds (to H.S.), and a research grant from AstraZeneca K.K. (to J.M.). The sponsors had no roles in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit the article for publication.
Funding Information:
During the last two years, H.S. received scholarship funds for the research from AstraZeneca K.K., Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Tsumura Co., and received service honoraria from Astellas Pharma Inc, AstraZeneca K.K., Otsuka Pharmaceutical Co. Ltd., Daiichi-Sankyo Co., Takeda Pharmaceutical Co. Ltd., Mylan EPD Co., and Zeria Pharmaceutical Co. Ltd. T.K. received scholarship funds for the research from Astellas Pharm Inc, Astra-Zeneca K.K., Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Eisai Pharmaceutical Co. Ltd., Zeria Pharmaceutical Co. Ltd., Tanabe Mitsubishi Pharmaceutical Co. Ltd., JIMRO Co. Ltd., Kyorin Pharmaceutical Co. Ltd., and received service honoraria from Astellas Pharm Inc, Eisai Pharmaceutical Co. Ltd., JIMRO Co. Ltd., Tanabe Mitsubishi Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Miyarisan Pharmaceutical Co. Ltd., and Zeria Pharmaceutical Co. Ltd. The other authors have nothing to declare.
Publisher Copyright:
© 2017, © Author(s) 2017.
PY - 2018/4/1
Y1 - 2018/4/1
N2 - Background: Impaired sleep quality is common, and can reduce work productivity in patients with functional dyspepsia (FD). Objective: The objective of this article is to evaluate whether there is a direct association between the presence of FD and the severity of impaired sleep quality, and to calculate the economic loss due to the decreased work productivity associated with sleep quality. Methods: In Study 1, using a web-based survey completed by workers with and without FD, we evaluated impaired sleep quality, work and daily productivity, and the severity of reflux and bowel symptoms. In Study 2, the association between the presence of FD and the severity of impaired sleep quality was validated in a hospital-based cohort. Results: In both Study 1 and 2, although impaired sleep quality was more frequent in participants with FD than in those without FD, the independent association between the presence of FD and the severity of impaired sleep quality was not observed after adjustment for the severity of reflux and bowel symptoms. FD participants with impaired sleep quality reported additional economic loss of 53,500 Japanese yen/month. Conclusion: Although the association between impaired sleep quality and FD was indirect, concomitant impaired sleep quality could worsen economic loss.
AB - Background: Impaired sleep quality is common, and can reduce work productivity in patients with functional dyspepsia (FD). Objective: The objective of this article is to evaluate whether there is a direct association between the presence of FD and the severity of impaired sleep quality, and to calculate the economic loss due to the decreased work productivity associated with sleep quality. Methods: In Study 1, using a web-based survey completed by workers with and without FD, we evaluated impaired sleep quality, work and daily productivity, and the severity of reflux and bowel symptoms. In Study 2, the association between the presence of FD and the severity of impaired sleep quality was validated in a hospital-based cohort. Results: In both Study 1 and 2, although impaired sleep quality was more frequent in participants with FD than in those without FD, the independent association between the presence of FD and the severity of impaired sleep quality was not observed after adjustment for the severity of reflux and bowel symptoms. FD participants with impaired sleep quality reported additional economic loss of 53,500 Japanese yen/month. Conclusion: Although the association between impaired sleep quality and FD was indirect, concomitant impaired sleep quality could worsen economic loss.
KW - Functional dyspepsia
KW - economic loss
KW - gastroesophageal reflux disease
KW - irritable bowel syndrome
KW - sleep disturbance
UR - http://www.scopus.com/inward/record.url?scp=85044414401&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044414401&partnerID=8YFLogxK
U2 - 10.1177/2050640617726466
DO - 10.1177/2050640617726466
M3 - Article
AN - SCOPUS:85044414401
SN - 2050-6406
VL - 6
SP - 398
EP - 406
JO - United European Gastroenterology Journal
JF - United European Gastroenterology Journal
IS - 3
ER -